Labcorp Loses Appeal in $372 Million Gene Testing Patent Case, Federal Circuit Upholds Decision

Labcorp, a significant player in the clinical laboratory industry, has encountered a setback in its legal pursuits as it lost an appeal related to a gene-testing patent. The dispute centers around a $372 million judgment from the Western District of Texas. The U.S. Court of Appeals for the Federal Circuit upheld an earlier administrative patent board decision against Labcorp, diminishing the company’s prospects in this ongoing litigation. This decision exemplifies the complexities involved in the intersection of intellectual property and biotech industries. For further details, see the comprehensive report in Law360.